Favilavir, formerly known as Fapilavir, an antiviral that has shown efficacy in treating the novel coronavirus, was approved for marketing, the Taizhou government in Zhejiang province announced Sunday.
It is the first anti-novel coronavirus drug that has been approved for marketing by the National Medical Products Administration since the outbreak. Developed by Zhejiang Hisun Pharmaceutical Company, the drug is expected to play an important role in preventing and treating the epidemic, the government said on its official WeChat account.
Favilavir is one of three drugs that have shown significant efficacy in treating the novel coronavirus in clinical trials, the Ministry of Science and Technology said on Saturday.
The antiviral was put into production on Sunday.
Zhejiang province has reported 1,167 cases so far.
Support Vessel 6711 and the Age of Adventure
Yalıkavak Marina: The Land of the Eternal Blue
Industry Brands Drop Anchor in Porto Montenegro
Hainan to build national sports tourism pilot zone
MYS Fleet in Focus: The Timeless Nature of Aquarius
€600,000 price drop on Mondomarine motor yacht My Way
72m Lürssen superyacht Coral Ocean for sale
Riva Opera motor yacht Sula sold
Regent Shanghai Pudong announced for this May
Motorsailer Yacht Le Pietre now for Sale with Engel & Volkers.
